Coming soon PAREA: A new psychedelic-focused alliance of prominent companies with common goals Multi-organization psychedelic partnership set to launch on June 23 Rowan DunneJune 16, 2022
Coming soon Germany takes further steps towards adult-use cannabis legalization Country known for high-end automobiles, Oktoberfest and a strong economy may soon join countries who have legalized cannabis Rowan DunneJune 15, 2022
Business Entheon Biomedical hands off DMT clinical study to Cybin Dimethyltryptamine continues to demonstrate tremendous therapeutic potential Rowan DunneJune 14, 2022
Business InMed Pharma rolls out rare cannabinoid via BayMedica D9-THCV one of many in company cannabinoid portfolio set to diversify and expand in coming years Rowan DunneJune 13, 2022
Canada Neptune Wellness set to make gradual exit from cannabis industry Company announces concentrated and strategic cost-cutting game plan moving forward Rowan DunneJune 10, 2022
Extraction Stirling CBD unveils potent new extracts Water-soluble cannabinoids provide wide-range of health benefits Rowan DunneJune 9, 2022
Canada Psilocybin and craft cannabis farmers to gather in B.C. Meeting for Vancouver Island growers and community leaders to be held on June 16. Rowan DunneJune 9, 2022
Canada B.C. pot shops customer privacy has improved: Commissioner report Privacy watchdog says province made strides to help protect customer information since 2021 Rowan DunneJune 9, 2022
Cannabis Tetra Bio-Pharma enters Australia via new subsidiary acquisition Canadian company set to focus clinical trials down under, announces regulatory update Rowan DunneJune 6, 2022
Psychedelics U.S. psychedelic drug market to reach $8.9B by 2029: DBMR report As rates of mental health disorders increase the demand for psychedelic treatments do too Rowan DunneJune 6, 2022